Drug: Celecoxib: chronic pain clinical trials

Registry records that list "Drug: Celecoxib" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

2 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Provinces
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" NCT00139776	Completed	Phase 4	Alberta, British Columbia, Newfoundland and Labrador, Ontario and 3 more	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	2005-07
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" NCT00139776	Completed	Phase 4	Alberta, British Columbia, Newfoundland and Labrador, Ontario and 3 more	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	2005-07

5 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain NCT03337607	Completed	Not applicable	China	First Affiliated Hospital of Zhejiang University	2017-11-13
Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain NCT02725411	Completed	Phase 3	Japan	Pfizer	2016-05-26
A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain NCT00662558	Completed	Phase 3	United States	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	2008-01
Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain NCT00904397	Terminated	Phase 4	United States	Endo USA Inc., a Keenova Therapeutics Company	2004-07
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer NCT00093678	Withdrawn	Not applicable		Eastern Cooperative Oncology Group

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.